Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) saw unusually-strong trading volume on Wednesday . ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) last posted its earnings results on Friday, May 15th. As a group, equities research analysts forecast that ARS Pharmaceuticals, Inc. will post -1.95 earnings per share for the current year. ARS Pharmaceuticals Company Profile(Get Free Report)ARS Pharmaceuticals, Inc, a biopharmaceutical company, develops treatments for severe allergic reactions. Featured StoriesReceive News & Ratings for ARS Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARS Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.